Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference
Rhea-AI Summary
Prestige Consumer Healthcare (NYSE:PBH) announced that CFO and COO Christine Sacco and VP Investor Relations, Treasury & Business Development Phil Terpolilli will join a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026 at 10:00 a.m. ET. A live webcast and replay will be accessible via the company’s investor relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – PBH
On Aug 11, the first trading day after this news, PBH closed 1.13% above the previous close.
Data tracked by StockTitan Argus for the Aug 11 session.
Key Figures
- Announcement date
- Aug. 10, 2026
- News announcement
- Conference edition
- 46th Annual Growth Conference
- Canaccord Genuity conference
- Conference date
- August 12, 2026
- Scheduled fireside chat
- Event time
- 10:00 a.m. ET
- Scheduled fireside chat
Historical Context
-
Revenue growth, higher adjusted EPS, and raised fiscal 2027 guidance
-
LaCorium acquisition closed alongside $400 million senior notes issuance
-
Company announced up to $400 million of senior unsecured notes
-
Company completed the $1.045 billion Breathe Right brand acquisition
-
Company announced participation in an Oppenheimer virtual fireside chat
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TARRYTOWN, N.Y., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Christine Sacco, CFO and COO, and Phil Terpolilli, VP, Investor Relations, Treasury, & Business Development will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday August 12, 2026 at 10:00 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
https://ir.prestigebrands.com/events-presentations/events
For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Breathe Right® nasal strips, Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, as well as Hydralyte® rehydration products and the Dermal Therapy® line of therapeutic skin care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact Phil Terpolilli, CFA, 914-524-6819 irinquiries@prestigebrands.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.